LPS suppresses expression of asialoglycoprotein-binding protein through TLR4 in thioglycolate-elicited peritoneal

Bruce Yong Ma1, Mio Kaihama, Motohiro Nonaka

  • 1Research Center for Glycobiotechnology, Ritsumeikan University, Shiga, 525-8577, Japan. byma@fc.ritsumei.ac.jp

Insights

Lipopolysaccharide (LPS) down-regulates macrophage asialoglycoprotein-binding protein (M-ASGP-BP) mRNA expression via the Toll-like receptor 4 (TLR4) pathway. This LPS-mediated suppression involves Nuclear Factor-kappaB (NF-kappaB) activation.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Macrophages utilize endocytosis receptors to clear pathogens.
  • Macrophage asialoglycoprotein-binding protein (M-ASGP-BP) is a Gal/GalNAc-specific lectin acting as an endocytosis receptor.

Purpose of the Study:

  • To investigate the effect of lipopolysaccharide (LPS) on M-ASGP-BP mRNA expression in macrophages.
  • To elucidate the molecular pathway involved in LPS-mediated regulation of M-ASGP-BP.

Main Methods:

  • Quantitative analysis of M-ASGP-BP mRNA expression in rat and mouse peritoneal macrophages.
  • Utilizing macrophages from C3H/HeN mice with a mutated Toll-like receptor 4 (TLR4).
  • Employing a Nuclear Factor-kappaB (NF-kappaB) inhibitor to assess its effect on LPS-induced M-ASGP-BP modulation.

Main Results:

  • LPS significantly down-regulated M-ASGP-BP mRNA expression in a time-dependent manner.
  • This suppressive effect was absent in macrophages from TLR4-mutated mice, indicating TLR4 dependence.
  • NF-kappaB inhibition blocked LPS-induced M-ASGP-BP suppression and IkappaB phosphorylation.

Conclusions:

  • LPS down-regulates M-ASGP-BP mRNA expression through the TLR4 pathway.
  • NF-kappaB activation is essential for the LPS-mediated suppression of M-ASGP-BP.
  • LPS binding to M-ASGP-BP may generate a negative signal that counteracts LPS-induced pro-inflammatory responses.